Powell Industries misses EPS estimate by $0.05 Powell Industries reported Q3 GAAP EPS of $1.42, missing the estimate by $0.05. Revenue was $312M, a 9.0% year-over-year increase, but fell short by $4.88M. The company saw significant growth in new orders, totaling $93
U.S. equities rise as traders await corporate results and key employment figures later this week. Wall Street’s main benchmarks advanced on Monday, with the Dow Jones Industrial Average gaining 1.3% and the S&P 500 closing in positive territory. Investors shifted focus to
U.S. commercial revenue surged 149% year-over-year, driving earnings above expectations and lifting full-year guidance. Palantir reported second-quarter revenue of $1.94 billion, up 93% from $1 billion a year earlier and exceeding the $1.80 billion estimate. Adjusted earni
Sabra Health Care's Q2 normalized AFFO beats prior metrics, though the company reports a net loss of $0.10 per share. Sabra Health Care reported Q2 normalized adjusted funds from operations (AFFO) of $0.40 per diluted common share, aligning with its reiterated guidance. Th
Investors piled into technology shares, driving the Nasdaq up 2.1% as markets brace for corporate earnings and key labor reports this week. US equities climbed on Monday, with the Nasdaq Composite rising 2.1% as investors rotated back into technology stocks. The S&P 500 al
Late July data reveals declining short positions in select large-cap consumer discretionary stocks amid a 5% sector decline. Short interest in several large and mega-cap consumer discretionary stocks fell in late July, reflecting shifting investor sentiment. The sector, tr
Microsoft, Meta, Nvidia, Alphabet, and Amazon rise at least 3.45%, led by Meta’s 6.58% advance amid broader market strength. Large-cap technology stocks surged as the S&P 500 rose 1.60% and the Nasdaq climbed 2.25%, with mega-cap names driving gains. Microsoft, Meta, Nvidi
La Rosa Holdings reports a GAAP EPS loss of $72.03 for Q1 2026 despite revenue growth in commercial brokerage services. La Rosa Holdings reported a first-quarter GAAP loss of $72.03 per share on revenue of $13.57 million. The company’s bottom line was weighed down by expen
Traders anticipate a 9.3% swing in PLTR shares following Monday’s second-quarter earnings release after market close. Palantir’s stock is poised for volatility as options markets imply a 9.3% move following its Q2 earnings report on Monday. Shares rose 2.13% to $125.68 in
TG Therapeutics down 11% after Q2 earnings miss TG Therapeutics reported Q2 earnings per share of $0.05, missing expectations. The company's Q2 EPS compares to $0.17 in the year-ago period. Revenue increased 70% year-over-year, but this was not enough to of
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.